Buccal Mucosal Graft for the Repair of Iatrogenic Pelviureteric Junction Obstruction or Ureteric Stricture.
Primary Purpose
Pelvi Ureteric Junction Obstruction or Ureteral Stricture
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
buccal mucosal graft to repair iatrogenic PUJO
Sponsored by
About this trial
This is an interventional treatment trial for Pelvi Ureteric Junction Obstruction or Ureteral Stricture
Eligibility Criteria
Inclusion Criteria:
- any patient with iatrogenic pelviureteric junction obstruction or long segment ureteric stricture
Exclusion Criteria:
- elderly patients unfit for general anaesthesia.
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Patients with iatrogenic PUJO
Arm Description
patients with iatrogenic PUJO or long segment ureteric stricture disease for safety and efficacy of using buccal graft for repair
Outcomes
Primary Outcome Measures
Number of Participants with patent renal pelvis and ureter after surgery.
3 months after surgery Diuretic renography will be done to judge patency of the pelvis and ureter and resolution of hydronephrosis
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04503330
Brief Title
Buccal Mucosal Graft for the Repair of Iatrogenic Pelviureteric Junction Obstruction or Ureteric Stricture.
Official Title
Using Buccal Mucosal Graft as an Augmention Graft for Complex Cases of Iatrogenic Pelviureteric Junction Obstruction and Long Segment Ureteric Stricture Disease.
Study Type
Interventional
2. Study Status
Record Verification Date
August 2020
Overall Recruitment Status
Unknown status
Study Start Date
October 1, 2020 (Anticipated)
Primary Completion Date
November 1, 2021 (Anticipated)
Study Completion Date
December 1, 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Cairo University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Prospective study to evaluate the safety and efficacy of using buccal mucosal graft for repairing complex cases of iatrogenic pelvi ureteric junction obstruction and long segment ureteric stricture disease.
Detailed Description
A graft of buccal mucosa will be used to augment either the narrow unhealthy pelviureteric junction or a narrow long segment of the ureter.
after freeing the narrowed part, a posterior incision will be made in the ureter or renal pelvis then the graft will be implanted on the psoas muscle using interrupted sutures in a position the allows easy anastomosis to the ureter or renal pelvis.
Alternatively a lateral incision in the renal pelvis or the ureter may be done for the graft anastomosis and then surrounded with omenal flap to ensure a good blood supply for the graft.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pelvi Ureteric Junction Obstruction or Ureteral Stricture
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
20 patients with iatrogenic pelviureteric junction obstruction or ureteric stricture disease
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Patients with iatrogenic PUJO
Arm Type
Experimental
Arm Description
patients with iatrogenic PUJO or long segment ureteric stricture disease for safety and efficacy of using buccal graft for repair
Intervention Type
Procedure
Intervention Name(s)
buccal mucosal graft to repair iatrogenic PUJO
Intervention Description
Augmented buccal mucosal graft anastomosis to repair iatrogenic PUJO or long segment ureteric stricture disease
Primary Outcome Measure Information:
Title
Number of Participants with patent renal pelvis and ureter after surgery.
Description
3 months after surgery Diuretic renography will be done to judge patency of the pelvis and ureter and resolution of hydronephrosis
Time Frame
3 months
10. Eligibility
Sex
All
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
- any patient with iatrogenic pelviureteric junction obstruction or long segment ureteric stricture
Exclusion Criteria:
elderly patients unfit for general anaesthesia.
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
study protocol statistical analysis results
IPD Sharing Time Frame
June 2021
IPD Sharing Access Criteria
through clinical trials webpage
Learn more about this trial
Buccal Mucosal Graft for the Repair of Iatrogenic Pelviureteric Junction Obstruction or Ureteric Stricture.
We'll reach out to this number within 24 hrs